SC: No Remand if the Appellate Court Can Decide the Issue on Existing Evidence  ||  SC: S.69 Evidence Act Applies to Will Only if S.68 Attestation Proof is Impossible  ||  SC: Superior’s Mere Reprimand Not Abetment of Suicide without Intent to Provoke Death  ||  SC: Speedy Trial is Victim’s Right; Gangsters Act Case Cannot Stall Other Trials  ||  Supreme Court Issues Directions to Curb Unaccounted Cash in Elections to Protect Democracy  ||  Supreme Court Issues Directions to Prevent Fake Sureties in Bail Cases Involving Foreigners  ||  Madras HC: Police Cannot Arbitrarily Bar Carrying Indian Flag at Peaceful Rallies  ||  Delhi HC Bars JNU from Granting Student Admissions Using Deprivation Points  ||  Kerala High Court Flags Misuse of POCSO in Marital Disputes and Acquits Man Accused of Rape  ||  Calcutta HC orders Urgent EWS Certificate Decision, Says Mother's Voter Deletion Irrelevant    

DCGI approves Phase II+III trials of Oxford University vaccine by Serum Institute, Pune- (Press Information Bureau) (03 Aug 2020)

MANU/PIBU/2397/2020

Civil

The Drugs Controller General of India (DCGI) has given approval to Serum Institute of India, Pune to conduct Phase II+III clinical trials of Oxford University-Astra Zeneca COVID-19 vaccine (COVISHIELD) in India. This will hasten the development of the COVID-19 vaccine.

India continues to improve the Case Fatality Rate (CFR), and maintain its global position of having one of the lowest COVID fatalities rates. With a further fall, the current CFR touched 2.11% today. This is the outcome of the well conceived and effectively implemented strategy of "Test, Track and Treat" which has guided the COVID management in the country.

The management strategy of COVID-19 also focuses on early detection and isolation of cases with seamless patient management and prioritising care of the high-risk population using field health care workers leading to increase in recoveries across the country. India has seen more than 40,574 patients recovered in the last 24 hours. This takes the total recoveries to 11,86,203 and Recovery Rate to 65.77% amongst COVID-19 patients.

With improving daily recovery number, the gap between the recovered cases & the active cases has increased to more than 6 lakh. Presently, it is 6,06,846. This means the actual active case load is 5,79,357 and all are under medical supervision.

Ministry of Health and Family Welfare has issued Revised Guidelines for International Arrivals in supersession of the Guidelines issued on the subject dated 24th May 2020. They will be operational from 00.01 Hrs, 8th August 2020.

Tags : APPROVAL   VACCINE   SERUM INSTITUTE  

Share :        

Disclaimer | Copyright 2026 - All Rights Reserved